A "sub-study" of a late-stage clinical trial found the drug, obicetrapib, significantly reduced levels of a certain type of ...

Merck's oral PCSK9 inhibitor enlicitide showed significant LDL-C reductions in two Phase 3 trials, with no major safety ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Shares of NewAmsterdam Pharma rose in premarket trading Monday after finding positive benefits for treating Alzheimer's Disease in its cholesterol drug study. Shares traded 9.2% higher ahead of the ...

Merck, which is evaluating the safety and efficacy of enlicitide for the treatment of adults with hyperlipidemia on lipid-lowering therapies, including at least a statin, said the Phase 3 studies met ...

The following chart lists some HIV medication side ... Treatment of hyperlipidemia includes taking cholesterol-lowering drugs, such as statins or fibrates. Lipodystrophy is also called fat ...

NewAmsterdam Pharma said Tuesday its cholesterol drug lowered the risk of major cardiovascular ... Cup With Handle Chart Pattern Over the course of a year, patients who received NewAmsterdam's ...

Statins, the more commonly used drugs, were also linked to some side effects. For example, some people taking statins might ...

Eli Lilly LLY announced that its investigational oral, once-daily cholesterol-lowering drug muvalaplin reduced ... Eli Lilly and Company price-consensus-chart | Eli Lilly and Company Quote To ...

You may need medication, too. But with lifestyle changes such as the TLC Program, you may be able to take lower doses. The goal of cholesterol treatment is to help you prevent a heart attack or ...

Ezetimibe is a cholesterol-lowering drug that is often prescribed with statins to reduce LDL even more. The research was presented Wednesday during a late-breaking science session at the ...

(Reuters) -Merck said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies.